Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $9.9 million.

  • Orthofix Medical's Capital Expenditures rose 7040.61% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year decrease of 2440.28%. This contributed to the annual value of $34.9 million for FY2024, which is 4379.37% down from last year.
  • According to the latest figures from Q3 2025, Orthofix Medical's Capital Expenditures is $9.9 million, which was up 7040.61% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's Capital Expenditures peaked at $21.9 million during Q3 2023, and registered a low of $2.5 million during Q3 2021.
  • In the last 5 years, Orthofix Medical's Capital Expenditures had a median value of $7.0 million in 2022 and averaged $8.5 million.
  • As far as peak fluctuations go, Orthofix Medical's Capital Expenditures soared by 32660.43% in 2023, and later crashed by 7342.72% in 2024.
  • Orthofix Medical's Capital Expenditures (Quarter) stood at $6.2 million in 2021, then rose by 12.47% to $7.0 million in 2022, then skyrocketed by 133.61% to $16.4 million in 2023, then tumbled by 47.84% to $8.5 million in 2024, then increased by 16.09% to $9.9 million in 2025.
  • Its Capital Expenditures stands at $9.9 million for Q3 2025, versus $7.1 million for Q2 2025 and $6.7 million for Q1 2025.